Rakesh Dixit

Company: Bionavigen

Job title: President & CEO

Seminars:

Fireside Chat: Understanding Toxicity & Immunogenicity Expectations From a Regulatory Standpoint 3:30 pm

Outlining the limited guidance from regulators when it comes to the immunogenicity / toxicity of LNPs Integrating feedback between different entities – between academia and industry to better understand what the current needs are Are there gold-standard protocols we should be following?Read more

day: Day Two

Panel Discussion: Evaluating the LNP-Carrier System Complex – mRNA vs. DNA vs. siRNA vs. saRNA 2:15 pm

Exploring novel modalities and novel ways of engineering and adding them to the LNPs Learning about the LNP-carrier system: if you have the same LNP and load it with an siRNA vs mRNA vs DNA you may elicit a different immune response / limiting toxicity Characterizing your LNP-payload complex to look at the impact on…Read more

day: Day Two